- Home
- Publications
- Publication Search
- Publication Details
Title
CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
Authors
Keywords
-
Journal
Viruses-Basel
Volume 10, Issue 1, Pages 40
Publisher
MDPI AG
Online
2018-01-17
DOI
10.3390/v10010040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection
- (2018) Songlin Yu et al. HUMAN GENE THERAPY
- Ebola virus disease: an update on post-exposure prophylaxis
- (2018) William A Fischer et al. LANCET INFECTIOUS DISEASES
- CRISPR/Cas9: at the cutting edge of hepatology
- (2017) Francis P Pankowicz et al. GUT
- Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma
- (2017) Elektra Peta et al. HUMAN PATHOLOGY
- The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2
- (2017) Dipon Das et al. JOURNAL OF VIROLOGY
- C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism
- (2017) Liang Liu et al. MOLECULAR CELL
- CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
- (2017) Lei Xu et al. MOLECULAR THERAPY
- In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
- (2017) Chaoran Yin et al. MOLECULAR THERAPY
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- A CRISPR toolbox to study virus–host interactions
- (2017) Andreas S. Puschnik et al. NATURE REVIEWS MICROBIOLOGY
- Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
- (2017) Stephen B. Kennedy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection
- (2017) Qiankun Wang et al. Retrovirology
- RNA editing with CRISPR-Cas13
- (2017) David B. T. Cox et al. SCIENCE
- Nucleic acid detection with CRISPR-Cas13a/C2c2
- (2017) Jonathan S. Gootenberg et al. SCIENCE
- Host cell restriction factors that limit transcription and replication of human papillomavirus
- (2017) Samuel S. Porter et al. VIRUS RESEARCH
- Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm
- (2017) Patrick Younan et al. mBio
- The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication
- (2017) Jie Wang et al. Theranostics
- Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
- (2017) Zhepeng Liu et al. Cell and Bioscience
- A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor
- (2017) Brook E. Heaton et al. Cell Reports
- The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases
- (2017) James T. Earnest et al. PLoS Pathogens
- Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9
- (2017) Hao Li et al. Frontiers in Cellular and Infection Microbiology
- Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era
- (2017) Daryl Anne Victoria Weatherley et al. Frontiers in Immunology
- A decade of discovery: CRISPR functions and applications
- (2017) Rodolphe Barrangou et al. Nature Microbiology
- The clinical applications of genome editing in HIV
- (2016) Cathy X. Wang et al. BLOOD
- Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA
- (2016) Takashi Yamano et al. CELL
- PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease
- (2016) Hui Yang et al. CELL
- CRISPR/Cas9-The ultimate weapon to battle infectious diseases?
- (2016) M. Doerflinger et al. CELLULAR MICROBIOLOGY
- Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
- (2016) R Kaminski et al. GENE THERAPY
- Lentivirus pre-packed with Cas9 protein for safer gene editing
- (2016) J G Choi et al. GENE THERAPY
- Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
- (2016) Christoph Seeger et al. MOLECULAR THERAPY
- Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
- (2016) Sheena M Saayman et al. MOLECULAR THERAPY
- CRISPR-mediated Activation of Latent HIV-1 Expression
- (2016) Prajit Limsirichai et al. MOLECULAR THERAPY
- Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter
- (2016) Haiyan Ji et al. MOLECULAR THERAPY
- The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA
- (2016) Ines Fonfara et al. NATURE
- A CRISPR screen defines a signal peptide processing pathway required by flaviviruses
- (2016) Rong Zhang et al. NATURE
- Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens
- (2016) Caleb D. Marceau et al. NATURE
- Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
- (2016) Alexandra East-Seletsky et al. NATURE
- Generation of knockout mice by Cpf1-mediated gene targeting
- (2016) Yongsub Kim et al. NATURE BIOTECHNOLOGY
- Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array
- (2016) Bernd Zetsche et al. NATURE BIOTECHNOLOGY
- Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells
- (2016) Daesik Kim et al. NATURE BIOTECHNOLOGY
- A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
- (2016) Ryan J Park et al. NATURE GENETICS
- KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8
- (2016) W Zhang et al. ONCOGENE
- C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
- (2016) Omar O. Abudayyeh et al. SCIENCE
- CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse
- (2016) Wei Zhu et al. VIRUS RESEARCH
- Brd4 Activates Early Viral Transcription upon Human Papillomavirus 18 Infection of Primary Keratinocytes
- (2016) Caleb C. McKinney et al. mBio
- A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
- (2016) Judd F. Hultquist et al. Cell Reports
- Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics
- (2016) George Savidis et al. Cell Reports
- Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
- (2016) Yan Feng et al. G3-Genes Genomes Genetics
- The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis
- (2016) Floriane Meuris et al. PLoS Pathogens
- The Replicative Consequences of Papillomavirus E2 Protein Binding to the Origin Replication Factor ORC2
- (2016) Marsha DeSmet et al. PLoS Pathogens
- Post-Transcriptional Regulation of KLF4 by High-Risk Human Papillomaviruses Is Necessary for the Differentiation-Dependent Viral Life Cycle
- (2016) Vignesh Kumar Gunasekharan et al. PLoS Pathogens
- CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections
- (2016) Ferdy R. van Diemen et al. PLoS Pathogens
- Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
- (2016) Sam Afkhami et al. Molecular Therapy-Methods & Clinical Development
- Inhibition of HSV-1 Replication by Gene Editing Strategy
- (2016) Pamela C. Roehm et al. Scientific Reports
- CRISPR/Cas9-Mediated Immunity to Geminiviruses: Differential Interference and Evasion
- (2016) Zahir Ali et al. Scientific Reports
- Highly specific targeted mutagenesis in plants using Staphylococcus aureus Cas9
- (2016) Hidetaka Kaya et al. Scientific Reports
- Efficient Production of Gene-Modified Mice using Staphylococcus aureus Cas9
- (2016) Xiya Zhang et al. Scientific Reports
- Efficient targeted mutagenesis of rice and tobacco genomes using Cpf1 from Francisella novicida
- (2016) Akira Endo et al. Scientific Reports
- Cpf1 Is A Versatile Tool for CRISPR Genome Editing Across Diverse Species of Cyanobacteria
- (2016) Justin Ungerer et al. Scientific Reports
- The Immunology of Epstein-Barr Virus–Induced Disease
- (2015) Graham S. Taylor et al. Annual Review of Immunology
- Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
- (2015) Chunsheng Dong et al. ANTIVIRAL RESEARCH
- Crystal Structure of Staphylococcus aureus Cas9
- (2015) Hiroshi Nishimasu et al. CELL
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus
- (2015) S Zhen et al. GENE THERAPY
- Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
- (2015) Jennifer L. Gori et al. HUMAN GENE THERAPY
- Application of CRISPR/Cas9 Technology to HBV
- (2015) Guigao Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
- (2015) Xing Liu et al. JOURNAL OF GENERAL VIROLOGY
- Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
- (2015) Chang Li et al. JOURNAL OF GENERAL VIROLOGY
- The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion
- (2015) Ran Yan et al. JOURNAL OF VIROLOGY
- Hepatitis B Virus-Infected HepG2hNTCPCells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+T CellsIn Vitro
- (2015) Alexander Hoh et al. JOURNAL OF VIROLOGY
- Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
- (2015) Sergey Shmakov et al. MOLECULAR CELL
- SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
- (2015) Yoshiko Usami et al. NATURE
- HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation
- (2015) Annachiara Rosa et al. NATURE
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
- (2015) Jianbin Wang et al. NATURE BIOTECHNOLOGY
- Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery
- (2015) Jianbin Wang et al. NUCLEIC ACIDS RESEARCH
- Cas9-mediated targeting of viral RNA in eukaryotic cells
- (2015) Aryn A. Price et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators
- (2015) Hal P. Bogerd et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
- (2015) Weijun Zhu et al. Retrovirology
- A Cas9-guide RNA complex preorganized for target DNA recognition
- (2015) F. Jiang et al. SCIENCE
- Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
- (2015) Blythe D. Sather et al. Science Translational Medicine
- Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
- (2015) Edward M. Kennedy et al. VIROLOGY
- Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
- (2015) Jie Wang WORLD JOURNAL OF GASTROENTEROLOGY
- CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
- (2015) Gero Hütter et al. Viruses-Basel
- Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
- (2015) Hsin-Kai Liao et al. Nature Communications
- Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
- (2015) Kei Miyakawa et al. Oncotarget
- CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
- (2015) Vyas Ramanan et al. Scientific Reports
- Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation
- (2015) Mingyu Lv et al. Scientific Reports
- A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR/Cas9 Library Screening of the Hepatitis C Virus
- (2015) Qingpeng Ren et al. Scientific Reports
- CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
- (2015) Madina Karimova et al. Scientific Reports
- Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
- (2015) Panpan Hou et al. Scientific Reports
- CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs
- (2015) Yonggang Zhang et al. Scientific Reports
- A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death
- (2015) Hongming Ma et al. Cell Reports
- Establishing a CRISPR–Cas-like immune system conferring DNA virus resistance in plants
- (2015) Xiang Ji et al. Nature Plants
- Conferring resistance to geminiviruses with the CRISPR–Cas prokaryotic immune system
- (2015) Nicholas J. Baltes et al. Nature Plants
- CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV
- (2015) Cheng Peng et al. VIROLOGICA SINICA
- Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?
- (2015) Xiuji Cui et al. PLoS One
- Establishment of three new genera in the family Geminiviridae: Becurtovirus, Eragrovirus and Turncurtovirus
- (2014) Arvind Varsani et al. ARCHIVES OF VIROLOGY
- Study of accuracy of colposcopy in VIA and HPV detection-based cervical cancer screening program
- (2014) Ishita Ghosh et al. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
- In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9
- (2014) Shuai Zhen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
- (2014) Hiroshi Nishimasu et al. CELL
- A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging
- (2014) Marvin E. Tanenbaum et al. CELL
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
- (2014) Pankaj K. Mandal et al. Cell Stem Cell
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells
- (2014) K.-S. Yuen et al. JOURNAL OF GENERAL VIROLOGY
- Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
- (2014) E. M. Kennedy et al. JOURNAL OF VIROLOGY
- TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism
- (2014) H. J. Fadel et al. JOURNAL OF VIROLOGY
- CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
- (2014) Rodolphe Barrangou et al. MOLECULAR CELL
- High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
- (2014) Yuexin Zhou et al. NATURE
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
- (2014) Weiming Wang et al. PLoS One
- RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
- (2014) J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
- (2014) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses
- (2014) Christian Königer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Generation of Marker-free Transgenic Plants Concurrently Resistant to a DNA Geminivirus and a RNA Tospovirus
- (2014) Ching-Fu Yang et al. Scientific Reports
- High-Efficiency Targeted Editing of Large Viral Genomes by RNA-Guided Nucleases
- (2014) Yanwei Bi et al. PLoS Pathogens
- The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
- (2014) Su-Ru Lin et al. Molecular Therapy-Nucleic Acids
- Targeting Hepatitis B Virus With CRISPR/Cas9
- (2014) Christoph Seeger et al. Molecular Therapy-Nucleic Acids
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
- (2013) Koichi Watashi et al. HEPATOLOGY
- Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
- (2013) Shirin Nkongolo et al. JOURNAL OF HEPATOLOGY
- Generation of an HIV Resistant T-cell Line by Targeted “Stacking” of Restriction Factors
- (2013) Richard A Voit et al. MOLECULAR THERAPY
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
- (2013) Guangwen Lu et al. NATURE
- A CRISPR/Cas system mediates bacterial innate immune evasion and virulence
- (2013) Timothy R. Sampson et al. NATURE
- Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
- (2013) Caroline Goujon et al. NATURE
- MX2 is an interferon-induced inhibitor of HIV-1 infection
- (2013) Melissa Kane et al. NATURE
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- CRISPR RNA–guided activation of endogenous human genes
- (2013) Morgan L Maeder et al. NATURE METHODS
- Geminiviruses: masters at redirecting and reprogramming plant processes
- (2013) Linda Hanley-Bowdoin et al. NATURE REVIEWS MICROBIOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System
- (2013) Tim Wang et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- HIV-1 eradication strategies
- (2013) Janet D. Siliciano et al. Current Opinion in HIV and AIDS
- The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells
- (2013) Asuka Nanbo et al. Scientific Reports
- Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
- (2013) Hirotaka Ebina et al. Scientific Reports
- Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
- (2012) Ana Blas-Garcia et al. CURRENT PHARMACEUTICAL DESIGN
- Ebola virus entry requires the host-programmed recognition of an intracellular receptor
- (2012) Emily Happy Miller et al. EMBO JOURNAL
- In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates
- (2012) Yu-Bing Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
- (2012) Tassilo Volz et al. JOURNAL OF HEPATOLOGY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Shock and kill
- (2012) Steven G. Deeks NATURE
- SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates
- (2012) Hichem Lahouassa et al. NATURE IMMUNOLOGY
- SAMHD1 restricts HIV-1 infection in resting CD4+ T cells
- (2012) Hanna-Mari Baldauf et al. NATURE MEDICINE
- SAMHD1: a new contributor to HIV-1 restriction in resting CD4+ T-cells
- (2012) Li Wu Retrovirology
- SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells
- (2012) Benjamin Descours et al. Retrovirology
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Developing strategies for HIV-1 eradication
- (2012) Christine M. Durand et al. TRENDS IN IMMUNOLOGY
- The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy
- (2012) Frauke Christ et al. VIROLOGY
- Novel mechanisms of EBV-induced oncogenesis
- (2012) Nancy Raab-Traub Current Opinion in Virology
- CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication
- (2012) Amanda J. Price et al. PLoS Pathogens
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
- (2011) Marceline Côté et al. NATURE
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
- (2011) Jan E. Carette et al. NATURE
- SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
- (2011) Nadine Laguette et al. NATURE
- Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
- (2011) Kasia Hrecka et al. NATURE
- T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus
- (2011) A. S. Kondratowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency
- (2011) Torsten Schaller et al. PLoS Pathogens
- Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
- (2011) I-Chueh Huang et al. PLoS Pathogens
- Heat Stress Cognate 70 Host Protein as a Potential Drug Target against Drug Resistance in Hepatitis B Virus
- (2010) Y. P. Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- Generation of human TRIM5α mutants with high HIV-1 restriction activity
- (2010) Q T Pham et al. GENE THERAPY
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
- (2010) Josiane E. Garneau et al. NATURE
- Heat shock protein 90 facilitates formation of the HBV capsid via interacting with the HBV core protein dimers
- (2010) Hee Youn Shim et al. VIROLOGY
- Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2
- (2010) Weihua Li et al. Virology Journal
- Characterization of Human Immunodeficiency Virus Type 1 Populations Containing CXCR4-Using Variants from Recently Infected Individuals
- (2009) Wei Huang et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components
- (2009) Martha R. Neagu et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Challenge of Finding a Cure for HIV Infection
- (2009) D. D. Richman et al. SCIENCE
- Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion
- (2009) Ravindra K. Gupta et al. PLoS Pathogens
- Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
- (2008) Renate König et al. CELL
- Genome-Scale RNAi Screen for Host Factors Required for HIV Replication
- (2008) Honglin Zhou et al. Cell Host & Microbe
- The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein
- (2008) Nanette Van Damme et al. Cell Host & Microbe
- Immunity to adeno-associated virus vectors in animals and humans: a continued challenge
- (2008) A K Zaiss et al. GENE THERAPY
- Human Immunodeficiency Virus Type 1 Restriction by Human–Rhesus Chimeric Tripartite Motif 5α (TRIM 5α) in CD34+ Cell-Derived Macrophages In Vitro and in T Cells In Vivo in Severe Combined Immunodeficient (SCID-hu) Mice Transplanted with Human Fetal Tissue
- (2008) Joseph Anderson et al. HUMAN GENE THERAPY
- Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
- (2008) Stuart J. D. Neil et al. NATURE
- Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
- (2008) Joerg Petersen et al. NATURE BIOTECHNOLOGY
- Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
- (2008) S. J. J. Brouns et al. SCIENCE
- Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen
- (2008) Abraham L. Brass et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started